What is the Org number of NorthX Biologics Holding AB?

NorthX Biologics Holding AB is registered with Bolagsverket / SCB under Org 5593371742.

Who is the CEO of NorthX Biologics Holding AB?

Adriana Jannetje Hoogstraate is Chief Executive Officer of NorthX Biologics Holding AB, in role since 2023.

Who is the chairman of NorthX Biologics Holding AB?

Thomas Bengt Eldered chairs the board of NorthX Biologics Holding AB, in role since 2022.

Riskpilot← Back to search

Sign inGet full access

NorthX Biologics Holding AB

ABActive

Org 5593371742Economic activity was not specified by tax authority · NACE 0000Est. 20210 employees

Overview Financials People & ownership Related companies

Financials

Revenue

SEK millions

EBITDA

SEK millions

Income statement

SEK thousands

Item	2021	2022	2023	2024
Revenue	0	0	0	0
Staff expenses	—	—	—	—
EBITDA	−787	−2 110	87 528	−1 176
Depreciation & amort.	−0	−0	−0	−0
EBIT	−787	−2 110	87 528	−1 176
Net financials	−8 276	−41 933	−12 764	−1 741
Profit before tax	−9 063	−16 310	14 323	−8 184
Tax	−0	−0	−0	−0
Net profit	−9 063	−16 310	14 323	−8 184

Balance sheet

SEK thousands

Item	2021	2022	2023	2024
Total assets	559 318	607 965	669 651	641 012
Equity	140 937	149 573	163 896	155 712
Long-term debt	351 843	382 895	362 079	412 565
Short-term debt	66 538	75 497	143 676	72 734
Total debt	418 381	458 392	505 755	485 299

Financial ratios

5-year trend

EBITDA margin

-117600000.0%

This company

15.8%

Market median

-744303897% vs market

20212024

Equity ratio

24.3%

This company

38.2%

Market median

-36% vs market

20212024

Return on equity

-5.3%

This company

18.4%

Market median

-129% vs market

20212024

Net profit margin

-818400000.0%

This company

8.1%

Market median

-10103703804% vs market

20212024

Asset turnover

0.00×

This company

1.12×

Market median

-100% vs market

20212024

Debt / equity

3.12×

This company

0.62×

Market median

-403% vs market

20212024

Annual reports & filings

Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-09-01 – 2021-12-31

NorthX Biologics Holding AB

Financials

Revenue

EBITDA

Income statement

Balance sheet

Financial ratios

Annual reports & filings

More on NorthX Biologics Holding AB

Financials

Revenue

EBITDA

Income statement

Balance sheet

Financial ratios

Annual reports & filings

More on NorthX Biologics Holding AB